Skip to content
IDDI
About Us
Why IDDI
Leadership
News
Events
Research Projects
Services
Strategic Consulting
Study Design
Regulatory Statistics
Randomization and Trial Supply Management
Clinical Data Management
Electronic Data Capture
SDTM – Data Standards Implementation
Biostatistics
Biostatistical Analysis
Interim Analysis – IDMC
ADaM – Data Standards Implementation
Therapeutic Expertise
Resources
Careers
Contact Us
Open Search
Search
Search
About Us
Why IDDI
Leadership
News
Events
Research Projects
Services
Strategic Consulting
Study Design
Regulatory Statistics
Randomization and Trial Supply Management
Clinical Data Management
Electronic Data Capture
SDTM – Data Standards Implementation
Biostatistics
Biostatistical Analysis
Interim Analysis – IDMC
ADaM – Data Standards Implementation
Therapeutic Expertise
Resources
Careers
Contact Us
Close Menu
Breast Cancer
Article
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in HER2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–HER2 Therapy
March 30, 2023
Article
Using disease free survival as a primary endpoint in early breast cancer
June 20, 2019
Trust Your Data to IDDI
Start Now